Search - tctmd.com

Displaying 221 - 240 of 1715

Sort: Relevancy | Date

Presentation TCT 2022

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Presenter: Bruno Scheller

September 17, 2022

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Presenter: Paul Underwood

September 17, 2022

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presenter: Antonio Colombo

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

Presenter: Eline Ploumen

November 06, 2021

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

The Role of Drug Coated Balloons in Bifurcation Lesions

Presenter: Robert Byrne

November 04, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

November 04, 2021

Presentation TCT 2021

TCT 719: Title: OCT guided management of old ISR and old unattended dissected vessel with Calcified Neoatherosclerosis using Cutting balloons and OPN followed by DES implantation

Presenter: Inderjeet Monga

November 04, 2021

Presentation TCT 2021

Recognizing the Value Proposition of DCB in the Real-World

Presenter: David Cohen

November 04, 2021

Advertisement

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

New Faces, New Formats, New Tech: What to Expect From TCT 2022

BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease

DCBs in Coronaries? Some Good News, but More Work Needed

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

The Role of Drug Coated Balloons in Bifurcation Lesions

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report: Final 5 Year Clinical Outcomes

TCT 719: Title: OCT guided management of old ISR and old unattended dissected vessel with Calcified Neoatherosclerosis using Cutting balloons and OPN followed by DES implantation

Recognizing the Value Proposition of DCB in the Real-World

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content